TheStreet cut shares of Nu Skin Enterprises Inc. (NYSE:NUS) from a buy rating to a hold rating in a research note issued to investors on Monday morning.

A number of other research firms have also issued reports on NUS. Pivotal Research boosted their price objective on Nu Skin Enterprises from $60.00 to $70.00 and gave the company a buy rating in a research note on Friday, August 5th. Deutsche Bank AG boosted their target price on Nu Skin Enterprises from $55.00 to $57.00 and gave the stock a buy rating in a research report on Friday, August 5th. Zacks Investment Research cut Nu Skin Enterprises from a buy rating to a hold rating in a research report on Thursday, October 27th. Citigroup Inc. boosted their target price on Nu Skin Enterprises from $66.00 to $69.00 and gave the stock a buy rating in a research report on Wednesday, September 21st. Finally, Bank of America Corp. set a $56.00 target price on Nu Skin Enterprises and gave the stock a sell rating in a research report on Sunday, November 6th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $56.25.

Nu Skin Enterprises (NYSE:NUS) traded up 0.81% during trading on Monday, reaching $53.60. The company’s stock had a trading volume of 515,198 shares. Nu Skin Enterprises has a 52-week low of $23.51 and a 52-week high of $66.04. The stock has a 50-day moving average price of $58.63 and a 200 day moving average price of $53.56. The company has a market cap of $2.92 billion, a PE ratio of 21.68 and a beta of 1.75.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Thursday, November 3rd. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.14. Nu Skin Enterprises had a return on equity of 20.06% and a net margin of 6.26%. The company had revenue of $604 million for the quarter, compared to analyst estimates of $583.74 million. During the same period in the previous year, the company posted $0.71 EPS. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, analysts expect that Nu Skin Enterprises will post $2.97 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Nu Skin Enterprises Inc. (NUS) Downgraded by TheStreet to Hold” was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this story on another publication, it was stolen and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at http://www.dailypolitical.com/2016/11/29/nu-skin-enterprises-inc-nus-downgraded-by-thestreet-to-hold.html.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 7th. Stockholders of record on Friday, November 18th will be issued a $0.355 dividend. This represents a $1.42 dividend on an annualized basis and a dividend yield of 2.65%. The ex-dividend date is Wednesday, November 16th. Nu Skin Enterprises’s payout ratio is currently 57.96%.

In other news, Chairman Steven Lund sold 61,000 shares of the business’s stock in a transaction dated Wednesday, October 26th. The stock was sold at an average price of $61.55, for a total value of $3,754,550.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Andrew D. Lipman sold 30,000 shares of the business’s stock in a transaction dated Thursday, September 22nd. The shares were sold at an average price of $64.13, for a total value of $1,923,900.00. Following the completion of the sale, the director now directly owns 36,090 shares of the company’s stock, valued at approximately $2,314,451.70. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.

Several large investors have recently added to or reduced their stakes in the stock. Washington Trust Bank raised its stake in Nu Skin Enterprises by 0.6% in the third quarter. Washington Trust Bank now owns 2,011 shares of the company’s stock worth $130,000 after buying an additional 11 shares during the period. Metropolitan Life Insurance Co. NY raised its stake in Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares during the period. Utah Retirement Systems raised its stake in Nu Skin Enterprises by 1.0% in the third quarter. Utah Retirement Systems now owns 10,000 shares of the company’s stock worth $648,000 after buying an additional 100 shares during the period. First Quadrant L P CA raised its stake in Nu Skin Enterprises by 0.5% in the second quarter. First Quadrant L P CA now owns 23,323 shares of the company’s stock worth $1,077,000 after buying an additional 123 shares during the period. Finally, BOKF NA raised its stake in Nu Skin Enterprises by 3.4% in the third quarter. BOKF NA now owns 8,689 shares of the company’s stock worth $563,000 after buying an additional 286 shares during the period. 76.44% of the stock is owned by institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

5 Day Chart for NYSE:NUS

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.